AcouSort AB (publ) (FRA:4SA)

Market Cap	7.64M +20.7%
Revenue (ttm)	916.08K +3.8%
Net Income	-956.91K
EPS	-0.05
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.2620
Previous Close	0.2840
Day's Range	0.2620 - 0.2620
52-Week Range	0.1240 - 0.4140
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 24, 2026

About AcouSort AB

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acoustic Separation Module, a microfluidic solution that provides continuous separation, washing or up-concentration of cells; Acoustic Trapping Module, a m...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2010
• Employees: 11
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4SA

Financial Performance

In 2025, AcouSort AB's revenue was 10.43 million, an increase of 4.01% compared to the previous year's 10.03 million. Losses were -12.15 million, -19.40% less than in 2024.

Financial numbers in SEK

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error